A Nordic Society of Gynecological Oncology (NSGO) multicenter, non-randomized, phase II study of docetaxel and carboplatin as second-line chemotherapy in patients with first elapse of platinum-sensitive epithelial ovarian, peritoneal or fallopian tube cancer
- Publication date
- Publisher
Abstract
Abstract is not available.
